Following the rains, Israel is awash with news of more successes in medical research, international trade and global recognition. Very appropriately we are about to celebrate the Jewish festival of Tu B’Shvat – The New Year for Trees and the time for the almond blossom.
ISRAEL’S MEDICAL ACHIEVEMENTS
Good results in pancreatic cancer treatment trials. Israel’s BioLineRx has announced encouraging initial results from its Phase 2a trials of its BL-8040 treatment on patients with metastatic pancreatic cancer. After only five days of treatment the treatment substantially increased the numbers of T-cells fighting the tumors.
https://www.prnewswire.com/news-releases/biolinerx-announces-partial-monotherapy-results-from-phase-2a-combat-study-in-pancreatic-cancer-300583808.html
Melanoma treatment shows promise. When Israel’s BioLineRx bought UK’s Agalimmune, it also acquired its AGI-134 treatment for solid tumors. BioLineRX has just demonstrated successful results of AGI-134 in two pre-clinical melanoma studies. https://www.prnewswire.com/news-releases/biolinerx-reports-data-at-asco-sitc-conference-showing-complete-tumor-regression-by-agi-134-in-pre-clinical-studies-670669553.html
Predicting and preventing PIE. Post Injury Epilepsy (PIE) occurs several months after a stroke in at least 10% of patients. Scientists at Ben Gurion University have been able to detect likely PIE sufferers using EEG (electroencephalographic) recordings of theta brain waves. Early treatment with medication can prevent attacks.
https://aabgu.org/discovered-biomarker-predicts-post-injury-epilepsy/
The gene that causes colon cancer. Israel’s NRGene has confirmed the identity of a genetic mutation that causes colon cancer in 60% of its hosts. NRGene was contacted by scientists at Stanford University and used its GenoMagic software to genetically screen the DNA of inherited colon cancer sufferers.
https://www.timesofisrael.com/israels-nrgene-successfully-identifies-colon-cancer-mutation/
European approval for stroke analysis system. (TY Atid-EDI) Viz.ai has received the CE Mark for its Israeli-developed Direct-to-Intervention system, ContaCT, a novel approach to stroke care that automatically analyzes brain CT-scans and notifies a specialist that a suspected large vessel occlusion has been identified.
https://interventionalnews.com/viz-ai-announces-ce-mark-first-artificial-intelligence-powered-direct-intervention-system/ https://www.youtube.com/embed/_721LqeON3U?rel=0
Personalized cancer treatment. (TY UWI and TIP) This video shows that Israeli doctors are saving lives of cancer patients by testing different treatments on samples of the tumors outside of the patient’s body. They can then determine the best cancer treatments to offer patients based on the success of the treatment.
https://www.youtube.com/embed/QK_4kO1VgPI?rel=0
Gene cancer therapy prepares to launch. Israel’s VBL Therapeutics has opened its new gene therapy production facility to manufacture VBL’s lead cancer therapy ofranergene obadenovec (VB-111), when finally approved. The Modiin gene therapy plant is one of the largest in the world, and the first in Israel.
https://globenewswire.com/news-release/2017/10/23/1151526/0/en/VBL-Therapeutics-Celebrates-Opening-of-its-New-Gene-Therapy-Manufacturing-Plant-and-Company-Headquarters.html
https://www.youtube.com/embed/4HeISdYw7d8?rel=0
An app to monitor the brain. Israel-based startup Montfort Brain Monitor won Israel’s Henry Ford Health System’s artificial intelligence challenge. Montfort’s “master app” uses a smartphone’s sensors to track a patient’s motor, cognitive, and affective activity. It can be tailored for the specific neurological disorder.
http://www.calcalistech.com/ctech/articles/0,7340,L-3730184,00.html
NIS 1 billion digital health project. In Davos, Israeli PM Netanyahu met with William McDermott, the CEO of SAP who agreed to partner with Israel on a new five-year NIS 1 billion digital healthcare project. The project aims to develop personalized and preventative medicine – regarded as a revolution in the health sector.
http://www.globes.co.il/en/article-netanyahu-sap-ceo-launch-nis-1b-healthcare-project-1001221143
ISRAEL IS INCLUSIVE AND GLOBAL